Articles

Icosapent ethyl for reduction of persistent cardiovascular risk: a critical review of major medical society guidelines and statements

Miller M, Tokgozoglu L, Parhofer KG, et al.

First published: July 28, 2022  DOI: 10.1080/14779072.2022.2103541